Two Sigma Securities, LLC Synthetic Biologics, Inc. Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.9 - $2.9 $60,910 - $92,968	32,058 Added 84.84%	69,844 $15,000
Q1 2022 May 16, 2022	BUY	$2.3 - $4.3 $86,907 - $162,479	37,786 New	37,786 $11,000
Q3 2020 Nov 16, 2020	SELL	$4.5 - $7.1 $90,031 - $142,049	-20,007 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$2.8 - $5.7 $56,019 - $114,039	20,007 New	20,007 $10,000
Q2 2019 Aug 14, 2019	SELL	$4.9 - $6.6 $92,399 - $124,456	-18,857 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.9 - $8.1 $111,256 - $152,741	18,857 New	18,857 $13,000
Q4 2018 Feb 14, 2019	SELL	$5.2 - $26.8 $58,858 - $303,349	-11,319 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$20.4 - $80.5 $230,907 - $911,179	11,319 New	11,319 $29,000

Ticker SYN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,844,100
Market Cap $9.51M
Description
Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.